Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
296.05
-1.50 (-0.50%)
May 13, 2025, 4:00 PM - Market closed
Penumbra Employees
Penumbra had 4,500 employees as of December 31, 2024. The number of employees increased by 300 or 7.14% compared to the previous year.
Employees
4,500
Change (1Y)
300
Growth (1Y)
7.14%
Revenue / Employee
$275,578
Profits / Employee
$9,385
Market Cap
11.46B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4,500 | 300 | 7.14% |
Dec 31, 2023 | 4,200 | 300 | 7.69% |
Dec 31, 2022 | 3,900 | 100 | 2.63% |
Dec 31, 2021 | 3,800 | 500 | 15.15% |
Dec 31, 2020 | 3,300 | 600 | 22.22% |
Dec 31, 2019 | 2,700 | 500 | 22.73% |
Dec 31, 2018 | 2,200 | 500 | 29.41% |
Dec 31, 2017 | 1,700 | 200 | 13.33% |
Dec 31, 2016 | 1,500 | 400 | 36.36% |
Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PEN News
- 14 days ago - Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference - PRNewsWire
- 14 days ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 19 days ago - Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst - Benzinga
- 20 days ago - Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Penumbra, Inc. Reports First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025 - PRNewsWire
- 5 weeks ago - Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits - PRNewsWire
- 2 months ago - Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors - PRNewsWire